Pei Gan

Person

Claymont, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,999,740
- Issue date Jun 4, 2024
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vinyl imidazole compounds as inhibitors of KRAS
- Patent number 11,999,752
- Issue date Jun 4, 2024
- Incyte Corporation
- Peter Carlsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
KRAS MODULATORS AND USES THEREOF
- Publication number 20250051365
- Publication date Feb 13, 2025
- Quanta Therapeutics, Inc.
- Hong LIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240343742
- Publication date Oct 17, 2024
- INCYTE CORPORATION
- Peter Carlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS
- Publication number 20240101557
- Publication date Mar 28, 2024
- INCYTE CORPORATION
- GENCHENG LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230056631
- Publication date Feb 23, 2023
- INCYTE CORPORATION
- Pei Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20220135570
- Publication date May 5, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20220064188
- Publication date Mar 3, 2022
- INCYTE CORPORATION
- Peter Carlsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20210139485
- Publication date May 13, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20200031835
- Publication date Jan 30, 2020
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20190292188
- Publication date Sep 26, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Fused pyrazine derivatives as A2A / A2B inhibitors

Vinyl imidazole compounds as inhibitors of KRAS

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Patents Applicationslast 30 patents

KRAS MODULATORS AND USES THEREOF

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS

FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS